Prognostic Value of18F-FDG PET/CT in Diffuse Large B-Cell Lymphoma Treated with a Risk-Adapted Immunochemotherapy Regimen

Journal article

Open access

Peer reviewed

Laure Michaud, Kurt Bantilan, Audrey Mauguen, Craig H. Moskowitz, Andrew D. Zelenetz and Heiko Schöder

Journal of Nuclear Medicine, Vol.64, pp.536-541

2022-12-22

Abstract

Radiology, Nuclear Medicine and imaging

url

https://doi.org/10.2967/jnumed.122.264740View

Published (Version of record) Open

1 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics: 1 Clinical & Life Sciences; 1.130 Lymphomas; 1.130.132 Lymphoma
Web Of Science research areas: Radiology, Nuclear Medicine & Medical Imaging
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Prognostic Value of18F-FDG PET/CT in Diffuse Large B-Cell Lymphoma Treated with a Risk-Adapted Immunochemotherapy Regimen
Creators: Laure Michaud - Memorial Sloan Kettering Cancer Center
Kurt Bantilan - Memorial Sloan Kettering Cancer Center
Audrey Mauguen - Memorial Sloan Kettering Cancer Center
Craig H. Moskowitz - University of Miami Health System
Andrew D. Zelenetz - Memorial Sloan Kettering Cancer Center
Heiko Schöder - Memorial Sloan Kettering Cancer Center
Publication Details: Journal of Nuclear Medicine, Vol.64, pp.536-541
Publisher: Society of Nuclear Medicine
Academic Unit: Miller School of Medicine; UMMG Department of Medicine
Language: English
Resource Type: Journal article
Record Identifier: 991031970904802976